Product Description
The
Hepatitis C Virus is a major global health problem affecting more than
170 million people. HCV can eventually lead to cirrhosis, liver
failure, and cancer in many instances. This volume will include
comprehensive original papers that cover much of the past, current, and
future literature that has appeared since the identification of the
hepatitis C virus RNA genome. It will specifically deal with the
effects of various types of interferons in basic research and clinical
outcomes of HCV disease and its progression. The novelty of this
publication will be that the immunobiology of HCV and the IFN-induced
modification of the immune response will be emphasized more clearly
then it has ever been in any other publication. It will be the
immunobiology section that will help readers better understand the
clinical efficacy of Interferon treatment. It will be a valuable volume
for the student, researcher, or clinician interested in HCV
transmission, molecular virology, immune response, cellular/molecular
pathogenesis, and possibilities for developing effective new
therapeutics and vaccines.